» Articles » PMID: 10544245

Hypoxia-induced Activation of HIF-1: Role of HIF-1alpha-Hsp90 Interaction

Overview
Journal FEBS Lett
Specialty Biochemistry
Date 1999 Nov 2
PMID 10544245
Citations 114
Authors
Affiliations
Soon will be listed here.
Abstract

The protein chaperone heat shock protein 90 (Hsp90) is a major regulator of different transcription factors such as MyoD, a basic helix loop helix (bHLH) protein, and the bHLH-Per-aryl hydrocarbon nuclear translocator (ARNT)-Sim (PAS) factors Sim and aryl hydrocarbon receptor (Ahr). The transcription factor hypoxia-inducible factor-1alpha (HIF-1alpha), involved in the response to hypoxia, also belongs to the bHLH-PAS family. This work was aimed to investigate the putative role of Hsp90 in HIF-1 activation by hypoxia. Using a EGFP-HIF-1alpha fusion protein, co-immunoprecipitation experiments evidenced that the chimeric protein expressed in COS-7 cells interacts with Hsp90 in normoxia but not in hypoxia. We also demonstrated that Hsp90 interacts with the bHLH-PAS domain of HIF-1alpha. Moreover, Hsp90 is not co-translocated with HIF-1alpha into the nucleus. At last, we showed that Hsp90 activity is essential for HIF-1 activation in hypoxia since it is inhibited in the presence of geldanamycin. These results indicate that Hsp90 is a major regulator in HIF-1alpha activation.

Citing Articles

[Research Progress in the Role of Hypoxia-Inducible Factor 1 in Altitude Sickness and the Mechanisms Involved].

Zhou Z, Sun F, Jiang B Sichuan Da Xue Xue Bao Yi Xue Ban. 2025; 55(6):1424-1435.

PMID: 39990820 PMC: 11839359. DOI: 10.12182/20241160303.


More than Just Protein Folding: The Epichaperome, Mastermind of the Cancer Cell.

Amissah H, Antwi M, Amissah T, Combs S, Shevtsov M Cells. 2025; 14(3).

PMID: 39936995 PMC: 11817126. DOI: 10.3390/cells14030204.


A closer look at the role of deubiquitinating enzymes in the Hypoxia Inducible Factor pathway.

Pauzaite T, Nathan J Biochem Soc Trans. 2024; 52(6):2253-2265.

PMID: 39584532 PMC: 11668284. DOI: 10.1042/BST20230861.


Heat shock proteins as hallmarks of cancer: insights from molecular mechanisms to therapeutic strategies.

Zuo W, Pang Q, Zhu X, Yang Q, Zhao Q, He G J Hematol Oncol. 2024; 17(1):81.

PMID: 39232809 PMC: 11375894. DOI: 10.1186/s13045-024-01601-1.


AUY922 improves sensitivity to sunitinib in clear cell renal cell carcinoma based on network pharmacology and in vitro experiments.

Chen Z, Jia X, Cai Y, Song Y, Tong Y, Cheng S Heliyon. 2024; 10(14):e34834.

PMID: 39149033 PMC: 11324986. DOI: 10.1016/j.heliyon.2024.e34834.